Relmada Therapeutics (RLMD) Stock Chart & Stock Price History → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free RLMD Stock Alerts $2.95 -0.09 (-2.96%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Relmada Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance-22.37%3 Month Performance-53.54%6 Month Performance+15.23%Year-To-Date Performance-28.74%1 Year Performance+11.32% Receive RLMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. RLMD Stock Chart for Sunday, June, 9, 2024 RLMD Chart by TradingView Relmada Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$3.04$2.95-2.96%$3.09$2.9098,168 shs$89.00 million06/06/2024$2.96$3.04+2.70%$3.06$2.9558,116 shs$91.72 million06/05/2024$2.95$2.96+0.34%$3.05$2.45511,381 shs$89.30 million06/04/2024$3.08$2.95-4.22%$3.18$2.88136,722 shs$89.00 million06/03/2024$3.00$3.08+2.67%$3.17$3.0040,082 shs$92.92 million05/31/2024$3.04$3.00-1.32%$3.16$2.9563,625 shs$90.51 million Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$2.93$3.04+3.75%$3.16$2.91129,477 shs$91.73 million05/29/2024$2.95$2.93-0.68%$3.00$2.9026,453 shs$88.40 million05/28/2024$3.05$2.95-3.28%$3.12$2.8665,141 shs$89.00 million05/27/2024$3.05$3.05$3.12$2.9692,000 shs$92.02 million05/24/2024$3.11$3.05-1.93%$3.12$2.9692,014 shs$92.02 million05/23/2024$3.09$3.11+0.65%$3.15$2.94119,724 shs$93.83 million05/22/2024$3.24$3.09-4.63%$3.27$3.09167,248 shs$93.23 million05/21/2024$3.24$3.24$3.35$3.13143,548 shs$97.75 million05/20/2024$3.34$3.24-2.99%$3.44$3.2463,318 shs$97.76 million05/17/2024$3.49$3.34-4.30%$3.50$3.3246,958 shs$100.77 million05/16/2024$3.48$3.49+0.29%$3.55$3.4643,530 shs$105.31 million05/15/2024$3.64$3.48-4.40%$3.75$3.4667,460 shs$104.99 million05/14/2024$3.53$3.64+3.12%$3.72$3.47100,042 shs$109.82 million05/13/2024$3.53$3.53$3.69$3.5058,248 shs$106.50 million05/10/2024$3.80$3.53-7.11%$3.88$3.5379,440 shs$106.50 million05/09/2024$3.83$3.80-0.78%$4.00$3.68101,030 shs$114.65 million05/08/2024$3.82$3.83+0.26%$3.95$3.7552,698 shs$115.55 million05/07/2024$3.85$3.82-0.78%$3.88$3.7765,817 shs$115.25 million05/06/2024$3.68$3.85+4.62%$4.00$3.6682,031 shs$116.17 million05/03/2024$3.72$3.68-1.08%$3.93$3.6392,858 shs$111.03 million05/02/2024$3.69$3.72+0.81%$3.78$3.7021,845 shs$112.23 million05/01/2024$3.64$3.69+1.37%$3.83$3.6264,008 shs$111.34 million04/30/2024$3.53$3.64+3.12%$3.74$3.46147,724 shs$109.82 million04/29/2024$3.83$3.53-7.83%$3.97$3.35241,668 shs$106.50 million04/26/2024$3.70$3.83+3.51%$3.87$3.6280,013 shs$115.55 million04/25/2024$3.86$3.70-4.15%$3.81$3.6685,873 shs$111.63 million04/24/2024$3.91$3.86-1.28%$3.96$3.75114,585 shs$116.46 million04/23/2024$3.87$3.91+1.03%$4.10$3.82143,632 shs$117.97 million04/22/2024$4.00$3.87-3.25%$4.06$3.70178,113 shs$116.76 million04/19/2024$4.30$4.00-6.98%$4.31$3.95152,611 shs$120.68 million04/18/2024$4.68$4.30-8.12%$4.72$4.2786,188 shs$129.73 million04/17/2024$4.56$4.68+2.63%$4.72$4.5285,164 shs$141.21 million04/16/2024$4.45$4.56+2.47%$4.61$4.3263,203 shs$137.58 million04/15/2024$4.65$4.45-4.30%$4.73$4.41125,022 shs$134.26 millionWrite this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution04/12/2024$4.66$4.65-0.21%$4.68$4.54120,024 shs$140.29 million04/11/2024$4.51$4.66+3.33%$4.81$4.50116,844 shs$140.59 million04/10/2024$4.80$4.51-6.04%$4.90$4.29158,446 shs$136.07 million04/09/2024$4.86$4.80-1.23%$5.09$4.7587,723 shs$144.82 million04/08/2024$4.59$4.86+5.88%$4.97$4.6463,172 shs$146.63 million04/05/2024$4.69$4.59-2.13%$4.84$4.53101,079 shs$138.48 million04/04/2024$4.71$4.69-0.42%$5.02$4.66178,512 shs$141.50 million04/03/2024$4.94$4.71-4.66%$5.09$4.68144,674 shs$142.10 million04/02/2024$4.88$4.94+1.23%$5.05$4.79136,589 shs$149.04 million04/01/2024$4.65$4.88+4.95%$5.00$4.60126,543 shs$147.23 million03/29/2024$4.65$4.65$4.71$4.50113,420 shs$140.29 million03/28/2024$4.59$4.65+1.31%$4.71$4.50113,100 shs$140.29 million03/27/2024$4.69$4.59-2.13%$4.82$4.40149,749 shs$138.48 million03/26/2024$4.90$4.69-4.29%$5.00$4.64103,407 shs$141.50 million03/25/2024$4.86$4.90+0.82%$5.13$4.68271,595 shs$147.83 million03/22/2024$4.66$4.86+4.29%$4.96$4.54267,508 shs$146.63 million03/21/2024$4.44$4.66+5.07%$4.66$3.99651,733 shs$140.27 million03/20/2024$5.37$4.44-17.41%$5.66$4.34687,629 shs$133.49 million03/19/2024$5.52$5.37-2.72%$5.84$5.36229,147 shs$161.64 million03/18/2024$5.42$5.52+1.85%$5.73$5.50123,586 shs$166.15 million03/15/2024$5.03$5.42+7.75%$5.53$4.80194,504 shs$163.14 million03/14/2024$5.64$5.03-10.82%$5.52$4.93163,092 shs$151.40 million03/13/2024$5.53$5.64+1.99%$5.76$5.57127,336 shs$169.76 million03/12/2024$5.77$5.53-4.16%$5.97$5.35221,233 shs$166.45 million03/11/2024$6.35$5.77-9.13%$6.38$5.76164,282 shs$173.68 million03/08/2024$6.37$6.35-0.31%$6.55$6.16119,024 shs$191.14 million Related Companies: Verrica Pharmaceuticals Stock Price Chart Amarin Stock Price Chart Precigen Stock Price Chart Neoleukin Therapeutics Stock Price Chart Shattuck Labs Stock Price Chart Ventyx Biosciences Stock Price Chart Nkarta Stock Price Chart Xeris Biopharma Stock Price Chart Nanobiotix Stock Price Chart Skye Bioscience Stock Price Chart Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RLMD) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companie...Banyan Hill Publishing | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.